American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

American Head & Neck Society | AHNS


The mission of the AHNS is to advance Education, Research, and Quality of Care for the head and neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Divison
        • Development Service Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Abstracts
    • Exhibitor and Support Opportunities
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Accredited Fellowships
      • Fellowship Match
      • Directory of Fellowships
      • Fellowship Curriculum
      • Certificate of Completion Request
      • Fellowship Graduates
      • For Program Directors
      • For Current AHNS Fellows
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland
    • Cutaneous Cancer
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Log In
  • Donate

Published on June 30, 2021 by Sufi Thomas

Sufi THomas – Kansas City, KS

Practice Contact Information

University of Kansas Medical Center
MS3040

Kansas City
KS
66160
United States

Phone: 9135886664
Email: [email protected]
Web Site: https://www.kumc.edu/school-of-medicine/otolaryngology/about-the-department/faculty-and-staff/faculty/sufi-thomas.html


Areas of surgical specialization in Head and Neck Surgery

Head and Neck Research


Biography/Statement

Sufi Mary Thomas, PhD, is an Associate Professor of Otolaryngology at the University of Kansas Medical Center. She holds secondary appointments in the Departments of Cancer Biology, and Anatomy and Cell Biology. In addition, she is a co-Leader in the Cancer Biology Program at the University of Kansas Cancer Center. Dr. Thomas completed her PhD at the University of Mumbai in India and post-doctoral fellowship at the University of Pittsburgh, Pennsylvania. Dr. Thomas specializes in head and neck cancer translational research. Her lab is currently delineating the mechanisms whereby non-malignant cells in the tumor microenvironment facilitate head and neck cancer progression and response to therapy. In addition, she is delineating mechanisms regulation late-effects of radiation, including radiation-induced fibrosis. She has published extensively, and helped develop several therapeutic approaches that have been tested in clinical trials. Her work is funded through the National Cancer Institute.

Clinical Trials

Bibliography

  1. New J, Arnold L, Ananth M, Alvi S, Thornton M, Werner L, Tawfik O, Dai H, Shnayder Y, Kakarala K, Tsue TT, Girod DA, Ding WX, Anant SA, Thomas SM. Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target. Cancer Res, 2017; 77 (23): 6679-6691 PMID: 28972076, PMCID: PMC5712244.
  2. Kumar D, New J, Vishwakarma V, Joshi R, Enders J, Lin F, Dasari S, Gutierrez W, Leef G, Ponnurangam S, Chavan H, Ganaden L, Thornton M, Dai H, Tawfik O, Straub J, Shnayder Y, Kakarala K, Tsue T, Girod D, Houten B, Shrikant A, Krishnamurthy P and Thomas SM. Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression. Cancer Research, 2018. Cancer Res, 2018:78(14): 3769-3782. PMID: 29769197 PMCID: PMC6050074.
  3. Kumar D, Yalamanchali S, New J, Parsel S, New N, Holcomb A, Gunewardena S, Tawfik O, Lominska C, Kimler BF, Anant S, Kakarala K, Tsue T, Shnayder Y, Sykes K, Padhye S, Thomas SM. Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis. Radiation Res. 2018, 189(3):326-336 PMID 29351058, PMCID: 29351058.
  4. Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis JR, Thomas SM. Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion. Br J Cancer. 2013 Dec 10;109(12):3049-56. PMC3859935
  5. Wheeler SE, Shi H, Lin F, Dasari S, Bednash J, Thorne S, Watkins S, Joshi R, Thomas SM. Tumor associated fibroblasts enhance head and neck squamous cell carcinoma proliferation, invasion and metastasis in preclinical models. Head & Neck, 2013, 35. PMCID: PMC4111913.
Views: 84

Share:

  • Facebook
  • Twitter
  • LinkedIn

Related

Contact Us

AHNS, 11300 W. Olympic Blvd, Suite 600
Los Angeles, CA 90064
ph: (310) 437-0559 / fx: (310) 437-0585
[email protected]

Search this website

Follow the AHNS

  • Email
  • Facebook
  • Twitter
  • YouTube

Recent Heads Up! Posts

AHNS ES Townhall on Focused Practice Designation for Adult Complex Thyroid/Parathyroid Surgery

Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award

Have you Read the Recent Study in NEJM about Neoadjuvant Cemiplimab in Advanced Resectable Cutaneous SCC from Dr. Neil Gross Et Al??

More News and Announcements

© 2002–2023 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc